GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income Including Noncontrolling Interests

IMGT (XKRX:456570) Net Income Including Noncontrolling Interests : ₩-11,235.04 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

IMGT's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was ₩-11,235.04 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-11,235.04 Mil.

IMGT Net Income Including Noncontrolling Interests Historical Data

The historical data trend for IMGT's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Net Income Including Noncontrolling Interests Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
-6,622.87 -16,912.67 731.32 4,082.37 -11,235.04

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests -6,622.87 -16,912.67 731.32 4,082.37 -11,235.04

IMGT Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-11,235.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMGT Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of IMGT's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XKRX:308080 XKRX:383930 XKRX:388610 XKRX:142760 XKRX:365270 XKRX:032790 XKRX:038070 XKRX:263050 XKRX:225220 XKRX:389030 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines